Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG in Previously Untreated Chronic Inflammatory Demyelinating Polyneuropathy
NCT00004286Phase 3Completed
- Sponsor
- National Center for Research Resources
- Start
- Feb 1996
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 3, randomised, double-blind trial in chronic inflammatory demyelinating polyneuropathy (CIDP) comparing IVIG with Placebo (2 arms). Primary endpoint: Clinical Response to Treatment at Day 43. Started Feb 1996; status: completed.
02
Drugs
Human normal immunoglobulin G
03
Conditions
chronic inflammatory demyelinating polyneuropathy (CIDP)
Beyond the preview
Go deeper on NCT00004286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004286.